EBO EBOS Group Limited

—Mkt Cap: —P/E: —

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare …

Industry Peers

Health Care Providers
Screen all

Key Statistics

Company
Market Cap—
Enterprise Value3.98B USD
Revenue (TTM)13.47B USD
Gross Profit1.19B USD
Net Income (TTM)153.43M USD
Revenue/Share117.23 NZD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees5.0K
CountryNZ
SectorHealthcare
IndustryHealth Care Providers
ISINNZEBOE0001S6
Valuation
P/E (Trailing)—
P/E (Forward)12.08
PEG4.34
EV/EBITDA15.22
EV/Revenue0.30
P/S0.18
P/B1.22
EPS (TTM)1.37
EPS (Forward)1.67
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin12.93%
Oper. Margin2.85%
EBITDA Margin3.46%
Profit Margin1.67%
ROE8.19%
ROA2.88%
Growth
Revenue Growth7.10%
Earnings Growth-7.10%
Cash Flow & Leverage
Operating CF348.39M USD
CapEx (TTM)49.50M USD
FCF Margin0.57%
FCF Yield—
Net Debt1.64B USD
Net Debt/EBITDA6.28
Balance Sheet
Debt/Equity0.69
Current Ratio1.16
Quick Ratio0.64
Book Value/Sh16.52 NZD
Cash/Share2.17 NZD
Dividends
Fwd Div Rate—
Trail. Div Rate1.76 NZD
Div. Yield5.99%
5Y Avg Yield3.02%
Payout Ratio89.28%
Ex-Div DateAug 27, 2026
Pay Date—
Splits
Last Split55:53
Split DateJun 4, 2013
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.61 NZD
Target Range22.44 NZD – 34.50 NZD
# Analysts8
Ownership
Shares Out.209.05M
Float196.87M
Insiders10.22%
Institutions20.14%
Technical
SMA 5020.53 NZD
SMA 20022.14 NZD
Beta0.17
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)155.67K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—